Title |
How Well Do Randomized Trials Inform Decision Making: Systematic Review Using Comparative Effectiveness Research Measures on Acupuncture for Back Pain
|
---|---|
Published in |
PLOS ONE, February 2012
|
DOI | 10.1371/journal.pone.0032399 |
Pubmed ID | |
Authors |
Claudia M. Witt, Eric Manheimer, Richard Hammerschlag, Rainer Lüdtke, Lixing Lao, Sean R. Tunis, Brian M. Berman |
Abstract |
For Comparative Effectiveness Research (CER) there is a need to develop scales for appraisal of available clinical research. Aims were to 1) test the feasibility of applying the pragmatic-explanatory continuum indicator summary tool and the six CER defining characteristics of the Institute of Medicine to RCTs of acupuncture for treatment of low back pain, and 2) evaluate the extent to which the evidence from these RCTs is relevant to clinical and health policy decision making. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 50% |
Members of the public | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 120 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 2% |
New Zealand | 1 | <1% |
Spain | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 115 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 25 | 21% |
Student > Bachelor | 14 | 12% |
Student > Ph. D. Student | 12 | 10% |
Researcher | 11 | 9% |
Other | 10 | 8% |
Other | 34 | 28% |
Unknown | 14 | 12% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 59 | 49% |
Nursing and Health Professions | 21 | 18% |
Agricultural and Biological Sciences | 6 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
Economics, Econometrics and Finance | 3 | 3% |
Other | 11 | 9% |
Unknown | 17 | 14% |